By Ransdell Pierson (Reuters) - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, bolstering J&J's role in the field after it acquired another experimental prostate-... More »
By Genevra Pittman NEW YORK (Reuters Health) - Watching and routinely examining men with early, slow-growing prostate cancer is more effective and cheaper than sending them to surgery or radiation right away, according to a new study. The findings... More »
By Genevra Pittman NEW YORK (Reuters Health) - After being diagnosed with prostate cancer, men who eat a diet high in vegetable fats, such as those in nuts and olive oil, may be less likely to have their disease spread, a new study suggests. Resea... More »
By Genevra Pittman NEW YORK (Reuters Health) - The proportion of middle-aged American men being treated for low testosterone more than tripled over the last decade, a new study suggests. Researchers analyzed health insurance claims for more than 1... More »
(Reuters) - The Food and Drug Administration has for the third time refused approval to Endo Health Solutions Inc's injectable testosterone drug Aveed, pressing for a still better plan to manage the risks associated with the drug. The denial c... More »
By Andrew M. Seaman NEW YORK (Reuters Health) - Men who get an older and less costly form of radiation after their cancerous prostates are removed fare just as well as men who get a new and expensive type of radiation, according to a new study. &q... More »
JOHANNESBURG (Reuters) - More than 20 South African boys have died over the past week during coming of age rituals, police said on Thursday, and they blamed botched circumcisions as the likely cause of death. Northern Mpumalanga province's pol... More »
By Andrew M. Seaman NEW YORK (Reuters Health) - Despite dietary supplements being popular among prostate cancer patients, a new review of past research says they are not effective treatments for the disease. Pulling together data from eight random... More »
By Toni Clarke (Reuters) - An advisory panel to the U.S. Food and Drug Administration was sharply divided on Thursday over whether a drug made by Endo Health Solutions Inc can safely be prescribed for men with low testosterone. A panel of outside ... More »
(Reuters) - Reviewers for the U.S. Food and Drug Administration said safety data on Endo Health Solutions Inc's twice-rejected testosterone injection Aveed was "concerning" and showed that the therapy was associated with severe and i... More »